The Graft Study

GvHD is an inflammatory disease that is common in people who have received a bone marrow transplant (for example cancer patients). GvHD causes the immune cells in the transplant to attack the organs. Unfortunately, there are limited treatment options and many die from GvHD. Because
the study drug works in a way that is different from existing treatments, it could help patients who do not respond to existing therapies.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.